Shari Annes | Investor Relations |
Rachel King | Chief Executive Officer |
Brian Hahn | Chief Financial Officer |
John Magnani | Chief Scientific Officer |
Eric Feldman | Chief Medical Officer |
Stephen Willey | Stifel |
Zegbeh Jallah | ROTH Capital Partners |
Steve Bersey | H.C. Wainwright |
Jason Bouvier | Jefferies |
Good morning and thank you for joining the GlycoMimetics Call. At this time, all participants are in listen-only mode.
Following management’s remarks, we will hold a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Shari Annes of Investor Relations Group at GlycoMimetics. Please go ahead.